Flexion Therapeutics Stock Forecast, Price & News

Flexion Therapeutics' stock was trading at $12.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FLXN stock has decreased by 1.1% and is now trading at $12.18.
View which stocks have been most impacted by COVID-19.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Flexion Therapeutics in the last year. There are currently 1 hold rating, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Flexion Therapeutics.

Flexion Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Flexion Therapeutics.

Flexion Therapeutics Inc (NASDAQ:FLXN) posted its quarterly earnings data on Wednesday, August, 5th. The specialty pharmaceutical company reported ($0.76) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.70) by $0.06. The specialty pharmaceutical company had revenue of $15.45 million for the quarter, compared to analyst estimates of $15.46 million.
View Flexion Therapeutics' earnings history.

13 brokers have issued 1-year price targets for Flexion Therapeutics' shares. Their forecasts range from $15.00 to $35.00. On average, they expect Flexion Therapeutics' stock price to reach $22.15 in the next twelve months. This suggests a possible upside of 81.9% from the stock's current price.
View analysts' price targets for Flexion Therapeutics.

Some companies that are related to Flexion Therapeutics include Pacira BioSciences (PCRX), I-Mab (IMAB), Seres Therapeutics (MCRB), Taro Pharmaceutical Industries (TARO), Xencor (XNCR), Aimmune Therapeutics (AIMT), Karuna Therapeutics (KRTX), Corcept Therapeutics (CORT), Madrigal Pharmaceuticals (MDGL), Aurinia Pharmaceuticals (AUPH), Amarin (AMRN), uniQure (QURE), Zymeworks (ZYME), IGM Biosciences (IGMS) and Akcea Therapeutics (AKCA).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Flexion Therapeutics investors own include Regulus Therapeutics (RGLS), Micron Technology (MU), NVIDIA (NVDA), Gilead Sciences (GILD), TherapeuticsMD (TXMD), Cara Therapeutics (CARA), Aduro BioTech (ADRO), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Verastem (VSTM).

Flexion Therapeutics trades on the NASDAQ under the ticker symbol "FLXN."

Flexion Therapeutics' stock is owned by a number of institutional and retail investors. Top institutional investors include Peregrine Capital Management LLC (1.06%), Assenagon Asset Management S.A. (0.05%) and Pacer Advisors Inc. (0.01%). Company insiders that own Flexion Therapeutics stock include C Ann Merrifield, David Arkowitz, Mark S Levine, Mark Stejbach, Michael D Clayman and Samuel D Colella.
View institutional ownership trends for Flexion Therapeutics.

FLXN stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC.
View insider buying and selling activity for Flexion Therapeutics.

FLXN stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., and Pacer Advisors Inc.. Company insiders that have bought Flexion Therapeutics stock in the last two years include C Ann Merrifield, David Arkowitz, Mark Stejbach, Michael D Clayman, and Samuel D Colella.
View insider buying and selling activity for Flexion Therapeutics.

Shares of FLXN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of FLXN stock can currently be purchased for approximately $12.18.

Flexion Therapeutics has a market capitalization of $600.51 million and generates $72.96 million in revenue each year. The specialty pharmaceutical company earns $-149,770,000.00 in net income (profit) each year or ($3.93) on an earnings per share basis. Flexion Therapeutics employs 288 workers across the globe.

The official website for Flexion Therapeutics is www.flexiontherapeutics.com.

Flexion Therapeutics' mailing address is 10 MALL ROAD SUITE 301, BURLINGTON MA, 01803. The specialty pharmaceutical company can be reached via phone at 781-305-7777 or via email at [email protected]